Loading...
Pramlintide Reduces the Risks Associated with Glucose Variability in Type 1 Diabetes
BACKGROUND: This study was designed to determine whether pramlintide added to insulin therapy reduced the risks associated with extreme blood glucose (BG) fluctuations in patients with type 1 diabetes. METHODS: Self-monitored BG (SMBG) records were retrospectively analyzed from a randomized, double-...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Mary Ann Liebert, Inc.
2008
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2979337/ https://ncbi.nlm.nih.gov/pubmed/18715216 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2007.0295 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|